ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 262

Is There a Role For Non-Mendelian Inheritance In Severe Osteoarthritis Of The Knee

Allen D. Sawitzke1, Richard Pimentel2, Jathine Wong2, Helena Martinez3, Marta Herrero3, Josep Verges4 and Daniel O. Clegg5, 1Rheumatology, University of Utah, Salt Lake City, UT, 2University of Utah, Salt Lake, UT, 3Pharmascience Division, Bioiberica S.A., Barcelona, Spain, 4Pharmacological Research Unit, Scientific Medical Department, Bioibérica, S.A., Barcelona, Spain, 5Rheumatology, George Wahlen VA Medical Center/University of Utah, Salt Lake City, UT

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Epidemiologic methods, genetic disorders and osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Title: Osteoarthritis - Clinical Aspects I: Risk Factors for and Sequelae of Osteoarthritis.

Session Type: Abstract Submissions (ACR)

Background/Purpose: Although the etiopathogenesis of osteoarthritis of the knee remains largely unknown, it is clear that genetic risks are contributory. Traditional family, twin, case control and GWAS designs have all contributed to the extensive knowledge in this area. Recently, groups have reported that mitochondrial genes are involved (1) and not-involved (2) in OA risk. The Utah Population Database (UPDB), a unique genealogic resource housed at the University of Utah has previously been used to study large founder pedigrees for evidence of many heritable diseases and we have used it to examine traditional Mendelian inheritance in OA of the knee. We hypothesized that these pedigrees could also be used to assess the potential role of non-Mendelian inheritance, specifically mitochondrial inheritance on the development of OA of the knee by comparing the statistical measures of mitochondrial models (MP) to autosomal models (AP) in these same founder families.

Methods: All OA cases who underwent TKA in Utah were selected based on billing codes in the International Classification of Diseases and data pulled from statewide hospital discharge data for a ten year period (1996-2007). Cases and controls matched for gender and age and their families were linked to the UPDB for analysis. The software kinship analysis tool (KAT) was used to analyze mitochondrial (MP) with autosomal (AP) by comparing familial standardized incidence ratio (FSIR) under each inheritance models. 

Results:

Over 18,000 OA patients who underwent TKA in Utah hospitals were linked to the UPDB and analysis performed for mitochondrial inheritance. The linkage resulted in 683 founder families with at least 5 affected members for analysis in comparison to randomly selected control families.

Pattern

FSIR

Extended Bayes FSIR

PAR

Autosomal Pattern

1

1.75 (1.61-1.91)

0.21 (0.18-0.24)

Mitochondrial Pattern

 1.015

 1.77 (1.61-1.96)

 0.14 (0.12-0.15)

MP had a very low population-attributable risk, PAR value, 14, where AP has a higher value of 0.21. It suggested approximately *% of the population who have OA of the knee could be from mitochondrial inheritance, whereas 21 percent of OA of the knee resulting in TKA are familial.

Conclusion:

The UPDB is a resource that has confirmed a Mendelian heritable risk for OA of the knee with a PAR of 21%. Now, it has also been used to shown non-Mendelian, in particular mitochondrial inheritance is not likely responsible for a large fraction of the heritability of OA of the knee severe enough to result in TKA as its associated PAR is 14. 

1.              Rego-Perez I, Fernandez-Moreno M, Fernandez-Lopez C, Arenas J, Blanco FJ. Mitochondrial DNA haplogroups: role in the prevalence and severity of knee osteoarthritis. Arthritis Rheum. 2008;58(8):2387-96.

2.              Hudson G, Panoutsopoulou K, Wilson I, Southam L, Rayner NW, Arden N, et al. No evidence of an association between mitochondrial DNA variants and osteoarthritis in 7393 cases and 5122 controls. Ann Rheum Dis. 2013;72(1):136-9.


Disclosure:

A. D. Sawitzke,

Bioiberica S.A.,

2,

Bioiberica S.A.,

8;

R. Pimentel,
None;

J. Wong,
None;

H. Martinez,

Bioiberica S.A.,

3;

M. Herrero,

Bioiberica,

3;

J. Verges,

Bioiberica S.A.,

3;

D. O. Clegg,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/is-there-a-role-for-non-mendelian-inheritance-in-severe-osteoarthritis-of-the-knee/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under embargo once the ACR has notified ­­­presenters of their abstract’s acceptance, and cannot be presented at other meetings after this time. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until November 7 at 10:00 AM ET. Journalists with access to embargoed information also cannot release articles before this time.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Permissions and Reprints

For information about abstract permissions and reprints, see ACR Convergence permissions and reprint policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2023 American College of Rheumatology